AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class treatment for autoimmune diseases as well as adding a novel RNA delivery ...

Yesterday, the biotechnology company Capstan Therapeutics launched with $165 million in seed and Series A funding for it to build on its foundational insights into precision in vivo engineering ...

NUS researchers have developed a platform that lets lab-grown muscle tissues train themselves to record-breaking strength, ...

The Mach 1 model was Ford’s best bang-for-buck offer in the seventies, with a V8-only list of engines ranging from the ...

A brain–machine interface (BMI) is a device that translates neuronal information into commands capable of controlling external software or hardware such as a computer or robotic arm. BMIs are often ...